跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 726 条关于
“ProteoNic BV”
全部
726
临床试验
411
药物
125
机构
90
资讯
100
9个月前
ProteoNic's 2G UNic Technology Licensed by Ginkgo Bioworks for $22.2M BARDA-Funded Anti-Filovirus Antibody Manufacturing Project
去年
ProteoNic Launches 2G UNic Transposon Platform for Enhanced Biologics Production
去年
Citryll Secures €85 Million in Series B Funding to Advance NET-Targeting Antibody CIT-013
去年
MeMed BV Test Reduces Antibiotic Overuse in Lower Respiratory Infections
上个月
Roche Receives FDA 510(k) Clearance for cobas® BV/CV Assay, Bringing PCR Precision to Vaginitis Diagnosis
2年前
Brentuximab Vedotin Triplet Shows Significant Survival Benefits in Relapsed/Refractory DLBCL
去年
Nivolumab Plus AVD Demonstrates Superior Progression-Free Survival in Advanced Hodgkin Lymphoma
去年
Brentuximab Vedotin Shows Strong Real-World Efficacy in Chinese ALCL Patients, Multi-Center Study Finds
去年
Nivolumab Plus Chemotherapy Improves PFS in Advanced Hodgkin Lymphoma
去年
Partner Treatment Halves Bacterial Vaginosis Recurrence Rate in Landmark Trial
第 1 页,共 10 页
上一页
下一页